14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $2.90 $4.87 Friday, 27th Jan 2023 CLBS stock ended at $3.55. This is 1.14% more than the trading day before Thursday, 26th Jan 2023. During the day the stock fluctuated 1.43% from a day low at $3.50 to a day high of $3.55.
90 days $2.90 $4.87
52 weeks $0.402 $9.75

Historical Caladrius Biosciences prices

Date Open High Low Close Volume
Jun 23, 2022 $0.538 $0.538 $0.525 $0.529 73 228
Jun 22, 2022 $0.540 $0.540 $0.520 $0.520 51 544
Jun 21, 2022 $0.523 $0.530 $0.520 $0.521 102 422
Jun 17, 2022 $0.510 $0.523 $0.500 $0.514 106 661
Jun 16, 2022 $0.509 $0.513 $0.495 $0.500 161 412
Jun 15, 2022 $0.465 $0.519 $0.465 $0.509 104 597
Jun 14, 2022 $0.506 $0.541 $0.500 $0.500 182 710
Jun 13, 2022 $0.538 $0.540 $0.499 $0.512 116 684
Jun 10, 2022 $0.567 $0.567 $0.533 $0.550 224 030
Jun 09, 2022 $0.520 $0.550 $0.520 $0.547 125 473
Jun 08, 2022 $0.550 $0.550 $0.495 $0.525 127 693
Jun 07, 2022 $0.501 $0.519 $0.491 $0.505 134 858
Jun 06, 2022 $0.519 $0.519 $0.500 $0.514 56 332
Jun 03, 2022 $0.510 $0.519 $0.503 $0.519 71 980
Jun 02, 2022 $0.510 $0.544 $0.495 $0.503 180 797
Jun 01, 2022 $0.500 $0.520 $0.490 $0.500 177 287
May 31, 2022 $0.470 $0.510 $0.465 $0.505 230 400
May 27, 2022 $0.480 $0.480 $0.452 $0.470 119 338
May 26, 2022 $0.454 $0.484 $0.450 $0.452 141 556
May 25, 2022 $0.460 $0.500 $0.450 $0.469 291 428
May 24, 2022 $0.460 $0.468 $0.460 $0.460 257 143
May 23, 2022 $0.462 $0.470 $0.460 $0.460 85 772
May 20, 2022 $0.462 $0.480 $0.462 $0.462 67 822
May 19, 2022 $0.457 $0.468 $0.457 $0.462 55 286
May 18, 2022 $0.456 $0.476 $0.456 $0.457 60 642
Click to get the best stock tips daily for free!

About Caladrius Biosciences

Caladrius Biosciences Caladrius Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellular therapies to reverse disease and/or promote the regeneration of damaged tissue. Its product candidates include HONEDRA, a recipient of SAKIGAKE designation that is in Phase II clinical trial for the treatment of critical limb ischemia; XOWNA that is in Phase IIb clinical trial for the treatment of coronary microvascular dysf... CLBS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT